查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1598469

局部給藥市場：按產品、給藥途徑和最終用戶 - 2025-2030 年全球預測

Topical Drug Delivery Market by Product (Liquid Formulations, Semi-Solid Formulations, Solid Formulations), Rout to Administration (Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，局部給藥市值為1149.6億美元，預計到2024年將達到1227.3億美元，複合年成長率為6.85%，到2030年將達到1828.5億美元。

局部給藥市場包括多種直接應用於皮膚和黏膜以提供局部和全身作用的產品。這種藥物傳遞非常重要，因為它可以針對特定部位，減少全身副作用並提高患者依從性。應用範圍從護膚治療到乾癬等慢性病的治療，再到局部疼痛緩解，最終使用領域包括居家醫療、醫院和商業藥房。關鍵的成長要素包括配方技術的進步、皮膚病的流行以及對疼痛管理和傷口護理的日益關注。先進的藥物輸送系統（例如經皮吸收貼片和微針）的出現，為提高輸送效率和患者舒適度創造了機會。對非侵入性方法和個人化醫療的需求正在推動藥物配方和材料的創新。然而，其成長面臨嚴格的法規環境、高昂的開發成本以及潛在的皮膚刺激和過敏反應的挑戰。此外，需要更一致的臨床試驗結果才能滿足監管和安全標準，這可能會阻礙新參與企業進入市場。市場參與企業可以利用對更俱生物相容性和永續性的材料、增強滲透技術以及結合局部和系統方法來實現最大有效性的混合系統的研究。奈米技術和生物技術的跨學科研究為制定高效的局部療法提供了一條有前途的途徑。儘管面臨挑戰，市場仍有望成長，重點關注擴大化妝品和非處方藥等應用領域。尋求競爭優勢的公司應優先考慮與研究機構合作，加速創新，並投資於教育客戶，以擴大有關外用製劑的好處和用途的市場。探索個人化治療解決方案並利用數位健康技術可以進一步促進成長和消費者參與。

主要市場統計
基準年[2023] 1149.6億美元
預測年份 [2024] 1227.3億美元
預測年份 [2030] 1828.5億美元
複合年成長率（%） 6.85%

市場動態：揭示快速發展的局部給藥市場的關鍵市場洞察

供需的動態交互作用正在改變局部給藥市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 皮膚病、眼科疾病及燒燙傷發生率高
    • 偏好經皮給藥
    • 醫療自我管理和居家照護的需要
  • 市場限制因素
    • 對替代藥物輸送的偏好
  • 市場機會
    • 資金籌措和投資以推進藥物輸送
    • 開發改進的治療劑標靶遞送
  • 市場挑戰
    • 關於皮膚刺激和滲透性的技術障礙
    • 藥品缺陷和產品召回

波特五力：駕馭局部給藥市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解局部給藥市場的外部影響

外部宏觀環境因素在塑造局部給藥市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解局部給藥市場的競爭格局

對局部給藥市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來發現自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣局部給藥市場供應商的績效評估

FPNV定位矩陣是評估局部給藥市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和局部描繪了局部給藥市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，局部給藥市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 皮膚病、眼科疾病率高，燒燙傷發生率高
      • 經皮給藥偏好
      • 醫療自我管理和居家照護的需要
    • 抑制因素
      • 對替代藥物傳遞方法的偏好
    • 機會
      • 為藥物輸送進步提供資金和投資
      • 開發改進的治療劑標靶遞送
    • 任務
      • 關於皮膚刺激和滲透性的技術障礙
      • 藥品故障和產品召回
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章局部給藥市場：依產品

  • 液體配方
    • 解決方案
    • 暫停
  • 半固態製劑
    • 奶油
    • 凝膠
    • 洗劑
    • 軟膏
    • 貼上
  • 固態製劑
    • 粉末
    • 栓劑
  • 經皮吸收產品
    • 經皮吸收貼片
    • 經皮固態藥物

第7章局部給藥市場從途徑到管理

  • 經經皮給藥
  • 鼻內給藥
  • 眼科藥物輸送
  • 直腸內給藥
  • 陰道內給藥

第8章局部給藥市場：依最終使用者分類

  • 燒燙傷中心
  • 家庭護理設置
  • 醫院/診所

第9章美洲局部給藥市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太局部給藥市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲的局部給藥市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Absorption Systems LLC
  • Bayer AG
  • Cipla Limited
  • Custom Converting, Inc.
  • Galderma Laboratories, LP
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Limited
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson Services, Inc.
  • MedPharm Ltd.
  • Mylan NV
  • Novartis AG
  • Novartis International AG
  • Pfizer Inc.
  • The Lubrizol Corporation
Product Code: MRR-4316E4E89103

The Topical Drug Delivery Market was valued at USD 114.96 billion in 2023, expected to reach USD 122.73 billion in 2024, and is projected to grow at a CAGR of 6.85%, to USD 182.85 billion by 2030.

The topical drug delivery market encompasses a broad range of products applied directly to the skin or mucous membranes, offering localized and systemic effects. This mode of drug delivery is critical due to its ability to target specific areas, reduce systemic side effects, and improve patient compliance. Applications range from skincare treatments to management of chronic conditions like psoriasis and localized pain relief, with end-use sectors including home healthcare, hospital, and commercial pharmacies. Key growth factors include technological advancements in formulation techniques, the prevalence of skin disorders, and the increasing inclination toward pain management and wound care therapies. The emergence of advanced drug delivery systems such as transdermal patches and microneedles creates opportunities to enhance delivery efficiency and patient comfort. The demand for non-invasive methods and personalized medicine drives innovation in drug formulation and materials. However, growth is challenged by the stringent regulatory environment, high development costs, and potential skin irritation or allergenic reactions. Additionally, there is a need for more consistent clinical trial outcomes to satisfy regulatory and safety standards, which can impede market entry for new players. Market players can capitalize on biocompatible and sustainable materials research, enhanced permeation techniques, and hybrid systems combining topical and systemic approaches for maximum efficacy. Cross-disciplinary research into nanotechnology and biotechnology offers promising avenues for formulating highly effective topical therapies. Despite challenges, the market is poised for growth with a strong focus on expanding application areas, including cosmeceuticals and over-the-counter medications. Companies looking to gain a competitive advantage should prioritize collaborations with research institutions to accelerate innovation and invest in market-expanding customer education about the benefits and applications of topical drug formulations. Exploring personalized therapy solutions and leveraging digital health technologies can further bolster growth and consumer engagement.

KEY MARKET STATISTICS
Base Year [2023] USD 114.96 billion
Estimated Year [2024] USD 122.73 billion
Forecast Year [2030] USD 182.85 billion
CAGR (%) 6.85%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Topical Drug Delivery Market

The Topical Drug Delivery Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High prevalence of skin and eye diseases and incidence of burn injuries
    • Preference for transdermal drug delivery
    • Need for medical self-administration and home care
  • Market Restraints
    • Preference for alternative modes of drug delivery
  • Market Opportunities
    • Funding and investments for drug delivery advancements
    • Development of improved targeted delivery of therapeutics
  • Market Challenges
    • Technical barriers related to skin irritation and permeability
    • Drug failures and product recalls

Porter's Five Forces: A Strategic Tool for Navigating the Topical Drug Delivery Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Topical Drug Delivery Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Topical Drug Delivery Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Topical Drug Delivery Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Topical Drug Delivery Market

A detailed market share analysis in the Topical Drug Delivery Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Topical Drug Delivery Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Topical Drug Delivery Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Topical Drug Delivery Market

A strategic analysis of the Topical Drug Delivery Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Topical Drug Delivery Market, highlighting leading vendors and their innovative profiles. These include Absorption Systems LLC, Bayer AG, Cipla Limited, Custom Converting, Inc., Galderma Laboratories, L.P., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson Services, Inc., MedPharm Ltd., Mylan N.V., Novartis AG, Novartis International AG, Pfizer Inc., and The Lubrizol Corporation.

Market Segmentation & Coverage

This research report categorizes the Topical Drug Delivery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Liquid Formulations, Semi-Solid Formulations, Solid Formulations, and Transdermal Products. The Liquid Formulations is further studied across Solutions and Suspensions. The Semi-Solid Formulations is further studied across Creams, Gels, Lotions, Ointments, and Pastes. The Solid Formulations is further studied across Powders and Suppositories. The Transdermal Products is further studied across Transdermal Patches and Transdermal Semi-Solids.
  • Based on Rout to Administration, market is studied across Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, and Vaginal Drug Delivery.
  • Based on End-User, market is studied across Burn Centers, Home Care Settings, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High prevalence of skin and eye diseases and incidence of burn injuries
      • 5.1.1.2. Preference for transdermal drug delivery
      • 5.1.1.3. Need for medical self-administration and home care
    • 5.1.2. Restraints
      • 5.1.2.1. Preference for alternative modes of drug delivery
    • 5.1.3. Opportunities
      • 5.1.3.1. Funding and investments for drug delivery advancements
      • 5.1.3.2. Development of improved targeted delivery of therapeutics
    • 5.1.4. Challenges
      • 5.1.4.1. Technical barriers related to skin irritation and permeability
      • 5.1.4.2. Drug failures and product recalls
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Topical Drug Delivery Market, by Product

  • 6.1. Introduction
  • 6.2. Liquid Formulations
    • 6.2.1. Solutions
    • 6.2.2. Suspensions
  • 6.3. Semi-Solid Formulations
    • 6.3.1. Creams
    • 6.3.2. Gels
    • 6.3.3. Lotions
    • 6.3.4. Ointments
    • 6.3.5. Pastes
  • 6.4. Solid Formulations
    • 6.4.1. Powders
    • 6.4.2. Suppositories
  • 6.5. Transdermal Products
    • 6.5.1. Transdermal Patches
    • 6.5.2. Transdermal Semi-Solids

7. Topical Drug Delivery Market, by Rout to Administration

  • 7.1. Introduction
  • 7.2. Dermal Drug Delivery
  • 7.3. Nasal Drug Delivery
  • 7.4. Ophthalmic Drug Delivery
  • 7.5. Rectal Drug Delivery
  • 7.6. Vaginal Drug Delivery

8. Topical Drug Delivery Market, by End-User

  • 8.1. Introduction
  • 8.2. Burn Centers
  • 8.3. Home Care Settings
  • 8.4. Hospitals & Clinics

9. Americas Topical Drug Delivery Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Topical Drug Delivery Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Topical Drug Delivery Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Absorption Systems LLC
  • 2. Bayer AG
  • 3. Cipla Limited
  • 4. Custom Converting, Inc.
  • 5. Galderma Laboratories, L.P.
  • 6. GlaxoSmithKline PLC
  • 7. Glenmark Pharmaceuticals Limited
  • 8. Hisamitsu Pharmaceutical Co., Inc.
  • 9. Johnson & Johnson Services, Inc.
  • 10. MedPharm Ltd.
  • 11. Mylan N.V.
  • 12. Novartis AG
  • 13. Novartis International AG
  • 14. Pfizer Inc.
  • 15. The Lubrizol Corporation

LIST OF FIGURES

  • FIGURE 1. TOPICAL DRUG DELIVERY MARKET RESEARCH PROCESS
  • FIGURE 2. TOPICAL DRUG DELIVERY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. TOPICAL DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. TOPICAL DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TOPICAL DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TOPICAL DRUG DELIVERY MARKET DYNAMICS
  • TABLE 7. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LOTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PASTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SUPPOSITORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL SEMI-SOLIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY NASAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY RECTAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY VAGINAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY BURN CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED KINGDOM